By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Dynogen Pharmaceuticals, Inc. 

52 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-839-5100 Fax: 781-839-5200


SEARCH JOBS


Industry
Pharmaceutical






Company News
Dynogen Pharmaceuticals, Inc. Files for Bankruptcy 2/25/2009 8:06:27 AM
Dynogen Pharmaceuticals, Inc. Presents Results of Its Positive Phase 2 IBS-d Study with DDP225 5/20/2008 6:08:12 AM
Dynogen Pharmaceuticals, Inc. to Present Positive Clinical Data for DDP225 and DDP733 4/30/2008 6:35:17 AM
Apex Bioventures (PEX) and Dynogen Pharmaceuticals, Inc. Mutually Terminate Merger Agreement 4/17/2008 9:54:46 AM
Apex Bioventures (PEX) and Dynogen Pharmaceuticals, Inc. Announce Definitive Merger Agreement 2/6/2008 8:51:45 AM
Dynogen Pharmaceuticals, Inc. Expands DDP225 Patent Estate 1/16/2008 8:30:21 AM
Dynogen Pharmaceuticals, Inc. Announces Positive Results in Phase 2 IBS-d Study 12/17/2007 9:03:37 AM
Dynogen Pharmaceuticals, Inc.'s Prokinetic Drug, DDP733, Enters Phase 2b for Irritable Bowel Syndrome with Constipation 11/8/2007 12:14:16 PM
Dynogen Pharmaceuticals, Inc.'s Prokinetic Drug, DDP733, Enters Phase 2b for Irritable Bowel Syndrome with Constipation 11/8/2007 10:02:16 AM
Dynogen Pharmaceuticals, Inc.'s Oral Prokinetic Drug, DDP733, Shown to Reduce Reflux in Phase 1B Study 10/15/2007 11:10:17 AM
123
//-->